These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 484233

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Menière's disease: diagnosis and management.
    Siriboonrit U, Jahn AF.
    N J Med; 1994 Mar; 91(3):171-3. PubMed ID: 8028805
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Menière's disease: dominant cochlear form. Its diagnosis].
    Hennebert PE.
    Acta Otorhinolaryngol Belg; 1979 Mar; 33(6):875-85. PubMed ID: 554419
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The status of the contralateral ear in established unilateral Menière's disease.
    Perez R, Chen JM, Nedzelski JM.
    Laryngoscope; 2004 Aug; 114(8):1373-6. PubMed ID: 15280710
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Meniere's disease or migraine? The clinical significance of fluctuating hearing loss with vertigo.
    Boyev KP.
    Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):457-9. PubMed ID: 15897428
    [No Abstract] [Full Text] [Related]

  • 29. Cochlear microphonics in Ménière's disease.
    Ge NN, Shea JJ, Orchik DJ.
    Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Long-term effects of Ménière's disease on hearing and quality of life.
    Kinney SE, Sandridge SA, Newman CW.
    Am J Otol; 1997 Jan; 18(1):67-73. PubMed ID: 8989954
    [Abstract] [Full Text] [Related]

  • 32. Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens.
    Toth AA, Parnes LS.
    J Otolaryngol; 1995 Dec; 24(6):340-4. PubMed ID: 8699599
    [Abstract] [Full Text] [Related]

  • 33. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT, Parnes LS.
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [Abstract] [Full Text] [Related]

  • 36. The natural course of Meniere's disease.
    Friberg U, Stahle J, Svedberg A.
    Acta Otolaryngol Suppl; 1984 May; 406():72-7. PubMed ID: 6591717
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Electrocochleography and the glycerol test in the diagnosis of Meniére's disease].
    Huang W.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1989 May; 24(1):26-9, 62-3. PubMed ID: 2641876
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cochlear conductive hearing loss in patients with Meniere's disease.
    Yetişer S, Kertmen M.
    Kulak Burun Bogaz Ihtis Derg; 2007 May; 17(1):18-21. PubMed ID: 17483606
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.